CHIZAP: Community- and Health Facility-Based Intervention With Zinc as Adjuvant Therapy for Childhood Pneumonia
Community- and Health Facility-based Intervention With Zinc as Adjuvant Therapy for Pneumonia to Enhance Child Health and Nutrition
Sponsor: All India Institute of Medical Sciences
Listed as NCT00148733, this PHASE2/PHASE3 trial focuses on Pneumonia and remains completed. Sponsored by All India Institute of Medical Sciences, it has been updated 11 times since 2004, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Jul 2025 — Present [monthly]
Completed PHASE2/PHASE3
-
Sep 2024 — Jul 2025 [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE2_PHASE3
▶ Show 6 earlier versions
-
Apr 2022 — Dec 2022 [monthly]
Completed PHASE2_PHASE3
-
Mar 2021 — Apr 2022 [monthly]
Completed PHASE2_PHASE3
-
Jan 2021 — Mar 2021 [monthly]
Completed PHASE2_PHASE3
-
Sep 2018 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
-
Jun 2018 — Sep 2018 [monthly]
Completed PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
First recorded
Jan 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- All India Institute of Medical Sciences
- Centre For International Health
- IRD, Epidemiologie et Prevention, Montpelier, France
- Society for Applied Studies
- Statens Serum Institut
- Tribhuvan University, Nepal
For direct contact, visit the study record on ClinicalTrials.gov .